New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 11, 2013
05:55 EDTAMED, AMED, BONT, BONT, COST, COST, KERX, KERX, RAVN, RAVN, SYPR, SYPRCompanies reporting Before the Market Open on Tuesday, March 12
Notable companies reporting before the opening bell on Tuesday include Amedisys (AMED), Bon-Ton Stores (BONT), Costco Wholesale (COST), Keryx Biopharmaceuticals (KERX), Raven Industries (RAVN), and Sypris Solutions (SYPR).
News For AMED;BONT;COST;KERX;RAVN;SYPR From The Last 14 Days
Check below for free stories on AMED;BONT;COST;KERX;RAVN;SYPR the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 21, 2014
10:35 EDTBONTSears falls after reporting Q2 loss that more than doubled analyst projections
Subscribe for More Information
07:05 EDTBONTBon-Ton Stores cuts FY14 EPS to 25c-55c from 40c-70c, consensus 57c
Cuts FY14 SSS to up 1%-2% from up 1%-3%; Cuts FY14 adjusted EBITDA to $165M-$175M from $170M-$180M; Sees FY14 gross margin rate flat up to 20 basis points. Sees FY14 SG&A expense rate flat to up 20 basis points. Sees FY14 estimated tax rate of 39%. Backs FY14 CapEx $75M. Cuts FY14 cash flow to $15M-$25M from $20M-$30M.
07:01 EDTBONTBon-Ton Stores reports Q2 SSS up 1.6%
Subscribe for More Information
07:01 EDTBONTBon-Ton Stores reports Q2 EPS ($1.86), consensus ($1.54)
Subscribe for More Information
August 20, 2014
15:26 EDTBONTNotable companies reporting before tomorrow's open
Subscribe for More Information
09:21 EDTRAVNRaven sees challenging revenue growth in Q3
Subscribe for More Information
09:19 EDTRAVNRaven reports Q2 EPS 21c, consensus 26c
Reports Q2 revenue $94.5M, one estimate $99.47M.
August 14, 2014
10:05 EDTKERXOn The Fly: Analyst Initiation Summary
Subscribe for More Information
05:35 EDTKERXKeryx initiated with a Market Perform at FBR Capital
Target $16.
August 11, 2014
06:57 EDTAMEDAvondale to hold a conference
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use